Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

NCT00095277 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen